Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.
Researchers are developing a system that combines a universal radioactive building block with different biological molecules to create new radiotracers.
The software supports amyloid, tau and FDG PET and provides automated Centiloid measurements for amyloid imaging and CenTauR measurements for tau imaging.
The launch comes ahead of meetings with members of Congress this fall in Washington, D.C., where group leaders plan to advocate for the availability of cardiac PET, particularly among underserved populations.
The finalized project was designed to increase production capacity and support growing demand for PET/CT technology, including new product lines planned for the United States and international markets.
The imaging agent could offer a new approach for diagnosing stiff heart syndrome, according to data presented during the European Society of Cardiology Congress.
New imaging research suggests that many adults who develop psychosis-related hallucinations or delusions later in life show brain changes associated with AD and other neurodegenerative disorders.
Published in eBioMedicine, the study indicates that individuals who have been diagnosed with long COVID display significantly decreased dopamine neuron integrity on brain scans
Once surgeons remove tumors, they use the scanner to determine whether the excised tissue is malignant, negating the need for additional pathology and enabling surgeons to precisely assess margins in real-time.
Though both modalities offer providers insight into the extent of a patient’s disease, WB-MRI may be more beneficial for patients than the current standard of care.
Though these treatments are typically done with assistance from real-time fluoroscopy, there is ample evidence nuclear imaging may offer more benefits.